GENT fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Gentian Diagnostics ASA engages in the research, development, production, marketing, and distribution of immunoassays. Its products include GCAL Calprotrectin, Crystatin C, Retinol-Binding Protein, Canine CRP, SARS-CoV-2 Total Ab, NT-proBNP Pre-Launch, BÜHLMANN products, IFU documents, and safety data sheets. The company was founded by Erling M. H. Sundrehagen and Bård Sundrehagen in 2001 and is headquartered in Moss, Norway.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
GENT does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future
Financial health
Financial position and solvency of the company